Track Categories

The track category is the heading under which your abstract will be reviewed and later published in the conference printed matters if accepted. During the submission process, you will be asked to select one track category for your abstract.

  • Track 1-1Medical and Clinical Oncology
  • Track 1-2Surgical Oncology
  • Track 1-3Radiation Oncology
  • Track 1-4Cardio-Oncology
  • Track 1-5Neuro-Oncology
  • Track 1-6Ocular oncology
  • Track 1-7Head & Neck Oncology
  • Track 1-8Thoracic Oncology
  • Track 1-9Veterinary Oncology
  • Track 1-10Dental Oncology
  • Track 1-11Molecular Oncology
  • Track 1-12Gastrointestinal Oncology
  • Track 1-13Cancers by Body Location
  • Track 1-14Types of Cancer
  • Track 1-15Cancer Therapies
  • Track 1-16Blood Investigation
  • Track 2-1Malignant Haematology and Thrombosis
  • Track 2-2Stem Cell Research and Hematology
  • Track 2-3Blood and its Components
  • Track 2-4Complete Blood Count
  • Track 2-5Hematology Research
  • Track 2-6Blood Disorders
  • Track 2-7Different Types of Blood Disease
  • Track 2-8Etiology
  • Track 3-1Gynaecologic Cancers
  • Track 3-2Urological Cancers
  • Track 3-3Haed and Neck Cancer
  • Track 3-4Tumors
  • Track 3-5Skin Cancer
  • Track 3-6Blood Cancer
  • Track 3-7Pancreatic and Colorectal Cancer
  • Track 3-8Brain Cancer
  • Track 3-9Oral Cancer
  • Track 3-10Liver Cancer
  • Track 3-11Lung Cancer
  • Track 3-12Prostate cancer
  • Track 3-13Gastrointestinal Cancer
  • Track 3-14Breast Cancer
  • Track 3-15Genetourinary Cancer
  • Track 4-1Acute and Chronic Lymphoblastic Leukemia
  • Track 4-2Hodgkins and Non-Hodgkins Lymphoma
  • Track 4-3Myelodysplastic Syndromes
  • Track 4-4Multiple Myelomas
  • Track 4-5Myeloma Cancer
  • Track 4-6Myeloid Leukemia
  • Track 5-1Management of Cancer
  • Track 5-2Cancer Treatment
  • Track 5-3Medical Oncology
  • Track 5-4Palliative Surgery
  • Track 5-5Breast Cancer Surgery
  • Track 5-6Bone & Soft Tissue Tumors  
  • Track 5-7Radiation Therapy or Hormone Therapy
  • Track 5-8Neo-adjuvant treatments
  • Track 5-9Oncoplastic and Reconstructive Surgery
  • Track 6-1Radiotherapy and Chemotherapy
  • Track 6-2Malignant Tumours
  • Track 6-3Cancer Diagnosis
  • Track 6-4Clinical Trials
  • Track 7-1Epigenomic
  • Track 7-2Cancer Genomics
  • Track 7-3Genome-Wide Methylation Arrays
  • Track 7-4Transcriptomics and Proteomics
  • Track 7-5Metabolite Profiling
  • Track 7-6Diagnostic Tools
  • Track 8-1Biopsy and Screening
  • Track 8-2Laboratory Tests
  • Track 8-3Chemotherapy and Radiation Therapy
  • Track 8-4Cancer Immunotherapy and Targeted Therapy
  • Track 8-5Endoscopy and Colonoscopy
  • Track 8-6Genetic Tests
  • Track 8-7Gene Therapy
  • Track 8-8Ultrasound
  • Track 9-1Red Blood Cell Disorders
  • Track 9-2Intravenous therapy
  • Track 9-3Therapeutic Drugs
  • Track 9-4Immune Thrombocytopenic Purpura
  • Track 9-5Anticoagulation Therapy
  • Track 9-6Complete Blood Count
  • Track 9-7Autoimmune Hemolytic Anemia
  • Track 9-8Bone Marrow Transplant
  • Track 9-9Prenatal Diagnosis
  • Track 9-10Stem Cell Transplantation
  • Track 10-1Blood Platelets Disorders
  • Track 10-2Red Blood Cell Disorders
  • Track 10-3White Blood Cell Disorder
  • Track 10-4Genetic Blood Disorders
  • Track 10-5Von Willebrand Disease
  • Track 10-6Molecular Pathogenesis
  • Track 10-7Coagulation Factors
  • Track 10-8Hemostasis and Congenital Disorders
  • Track 10-9Hemophilia
  • Track 10-10Thalassemia
  • Track 10-11Hemoglobinopathies
  • Track 10-12Thrombocytopenia
  • Track 10-13Anemia
  • Track 10-14Hemorrhagic Disorders
  • Track 11-1Umbilical Cord Blood Transplantation
  • Track 11-2Bone Marrow Transplantation
  • Track 11-3Autologous Transplantation
  • Track 11-4Allogeneic stem cell transplants
  • Track 11-5Hematopoitic bone marrow Transplantation
  • Track 11-6Neonatology
  • Track 11-7Immunological reactions
  • Track 12-1Brain Tumors
  • Track 12-2Psychological Issues
  • Track 12-3Paediatric Oncology Nursing
  • Track 12-4Malignancies in Children 
  • Track 12-5Diagnosis and Treatment
  • Track 12-6Risk Factors
  • Track 13-1Cancer Immunotherapies
  • Track 13-2Clinical Immunology
  • Track 13-3Immunoediting
  • Track 13-4Immunosurveillance
  • Track 14-1Genetic markers
  • Track 14-2Diagnostic Biomarker
  • Track 14-3Biomarker Discovery
  • Track 14-4Tumor Markers
  • Track 14-5Cancer biomarkers
  • Track 15-1Drug combinations
  • Track 15-2Drug action
  • Track 15-3Oncovaccines
  • Track 15-4Traditinal Vaccines
  • Track 15-5Clinical Trials
  • Track 15-6Pharmacotherapy
  • Track 16-1Hematological Nurse
  • Track 16-2Pathology and Imaging Studies
  • Track 16-3Diagnose and Treat Blood Diseases
  • Track 16-4Pediatric Oncology Nurse
  • Track 16-5Pain Management
  • Track 16-6Patient-Facing
  • Track 17-1Cancer Pharmaceutical Companies
  • Track 17-2Biological Drugs
  • Track 17-3Generic Drugs
  • Track 17-4Healthcare Expenditures
  • Track 18-1Fresh frozen plasma
  • Track 18-2Dried factors
  • Track 18-3Diagnostic Equipments
  • Track 18-4Technological Advancements
  • Track 18-5Performance Based Market
  • Track 19-1Diagnostic Approach
  • Track 19-2Guidelines
  • Track 19-3Check Reports